Patient Rights & Responsibilities

Patient Rights Privacy while receiving care. Dignity and respect while receiving care. Confidentiality of information. Personal safety and security. Informed consent. Refusal of treatment only after signing the informed consent after the consultation of the concerned treating physician Access to his/her medical record Right to the complaint and seek fair solution. Rights to information of… Continue reading Patient Rights & Responsibilities


The following are the list of material list of creditors: List of Material Creditors Amount Eisai Pharmaceuticals India Pvt Ltd 161,532,060 Allergan Healthcare India Pvt. Ltd 34,006,138 Total Material Creditors 195,538,198

Corporate Social Responsibility

CONTEXT Healthvista India Limited (“the Company”) has been an early adopter of corporate social responsibility (“CSR”) initiatives. The Company’s CSR Initiatives works towards removing malnutrition, improving healthcare infrastructure, supporting primary education, rehabilitating destitute individuals and caring for animals, and preserving Indian art and culture. We partner with non-government organizations (NGOs) to make a difference among… Continue reading Corporate Social Responsibility

Succession Policy

Introduction In accordance with the provision of Regulation 17(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 as amended, the board of directors (the “Board”) of Healthvista India Limited (the “Company”) has adopted this policy (“Succession Policy”) on 27th June 2022 upon the recommendation of the Nomination and… Continue reading Succession Policy

Risk Management Policy

Introduction: Healthvista India Limited (“the Company”) considers ongoing risk management to be a core component of the Management of the Company, and understands that the Company’s ability to identify and address risk is central to achieving its corporate objectives. The Company’s Risk Management Policy (“the Policy”) outlines the program implemented by the Company to ensure… Continue reading Risk Management Policy

Preservation Documents Policy

POLICY FOR PRESERVATION OF DOCUMENTS PREFACE AND OBJECTIVE The Board of Directors (the “Board”) of the Healthvista India Limited (the “Company”) has approved the following policy for preservation of documents in terms of Regulation 9 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to… Continue reading Preservation Documents Policy

Board Diversity Policy

Board Diversity Policy Adopted by the Board on 27th June 2022 This Board Diversity Policy, which is in terms of Schedule II Part D (A)(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (“SEBI Listing Regulations”), sets out the approach to diversity… Continue reading Board Diversity Policy

Archival Policy

Introduction: In terms of Regulation 30(8) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “SEBI Listing Regulations”), requires every listed company is required to disclose on its website all such events or information which has been disclosed to stock exchanges where the securities of the Company are… Continue reading Archival Policy

Approach on Disclosure of Approvals

DILIGENCE APPROACH: Business approvals: We note that registrations under the following legislations are relevant to the business activities undertaken by the Company and its subsidiaries: Clinical Establishments (Registration & Regulation) Act, 2010 (“Clinical Establishments Act“”) The Karnataka Private Medical Establishment Act, 2007 (“Karnataka Medical Establishment Act”) Drugs and Cosmetics Act, 1940 (“Drugs and Cosmetic Act”)… Continue reading Approach on Disclosure of Approvals